Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Alogliptin and voglibose
Takeda
Type 2 Diabetes Mellitus
2 trials -
Amlodipine
Takeda
Hypertension
1 trial -
Anagrelide Hydrochloride
Takeda
Essential Thrombocythemia (ET)
1 trial -
Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
Takeda
Major Depressive Disorder
3 trials -
Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)
Takeda
Hemophilia A
1 trial -
Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)
Takeda
Hemophilia A
1 trial -
Azacitidine
Takeda
Myelodysplastic Syndrome
1 trial -
Azilsartan
Takeda
Pediatric Hypertension
2 trials -
Azilsartan Medoxomil
Takeda
Hypertension
7 trials -
Azilsartan Medoxomil and amlodipine
Takeda
Hypertension
1 trial -
Azilsartan medoxomil and chlorthalidone
Takeda
Safety
1 trial -
Azilsartan medoxomil and chlorthalidone
Takeda
Hypertension
2 trials -
Azilsartan medoxomil and chlorthalidone
Takeda
Essential Hypertension
4 trials -
Azilsartan medoxomil and olmesartan
Takeda
Hypertension
1 trial -
Azilsartan medoxomil with or without add-on chlorthalidone
Takeda
Hypertension
1 trial -
Azilsartan medoxomil/placebo
Takeda
Essential Hypertension
1 trial -
BAX 326
Takeda
Hemophilia B
1 trial -
BAX 326 (Recombinant factor IX)
Takeda
Hemophilia B
1 trial -
BAX326
Takeda
Hemophilia B
1 trial -
BAX855
Takeda
Hemophilia A
1 trial -
Brentuximab Vedotin
Takeda
Primary Cutaneous Anaplastic Large Cell Lymphoma
1 trial -
Brentuximab vedotin
Takeda
Diffuse Large B-cell-lymphoma
1 trial -
Brigatinib
Takeda
ALK+ Advanced NSCLC
1 trial -
Budesonide oral suspension
Takeda
Eosinophilic Esophagitis (EoE)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources